Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

Williams, John G; Alam, Fasihul; Alrubaiy, Laith; Arnott, Ian; Clement, Clare; Cohen, David; Gordon, John N; Hawthorne, A Barney; Hilton, Mike; Hutchings, Hayley; Jawhari, Aida U; Longo, Mirella; Mansfield, John; Morgan, Jayne M; Rapport, Frances; Seagrove, Anne C; Sebastian, Shaji; Shaw, Ian; L, Simon P; Watkins, Alan; Williams, John

doi:10.1016/s2468-1253(16)30003-6

Journal article 1456 views 229 downloads

Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

John G Williams, Fasihul Alam, Laith Alrubaiy

, Ian Arnott, Clare Clement, David Cohen, John N Gordon, A Barney Hawthorne, Mike Hilton, Hayley Hutchings

, Aida U Jawhari, Mirella Longo, John Mansfield, Jayne M Morgan, Frances Rapport, Anne C Seagrove, Shaji Sebastian, Ian Shaw, Simon P L Travis, Alan Watkins

, John Williams

The Lancet Gastroenterology & Hepatology, Volume: 1, Issue: 1, Pages: 15 - 24

Swansea University Authors: Fasihul Alam, Laith Alrubaiy , Hayley Hutchings , Alan Watkins , John Williams

PDF | Version of Record

Distributed under the terms of a Creative Commons Attribution CC-BY Licence.
Download (439.81KB)

Check full text

DOI (Published version): 10.1016/s2468-1253(16)30003-6

Published in:	The Lancet Gastroenterology & Hepatology
ISSN:	2468-1253
Published:	Elsevier BV 2016
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa29773

College:	Faculty of Medicine, Health and Life Sciences
Issue:	1
Start Page:	15
End Page:	24

Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

Similar Items